وكالة مدار نيوز
وكالة مدار نيوز
Ready to play
Ready to play
Here is the summary of the article about a revolution in cancer treatment using vaccines based on mRNA (messenger RNA) technology: Reports confirm that mRNA vaccine technology represents a revolutionary breakthrough in cancer treatment, showing successful results in developing personalized vaccines to combat types such as melanoma, lung cancer, and pancreatic cancer. Moderna and Merck have achieved significant successes in phase three trials of their anti-cancer vaccines, which help reduce the risk of melanoma recurrence. Current research is focusing on designing individualized vaccines based on analyzing each patient's genetic mutations, allowing the immune system to target cancer cells more precisely and rapidly. This approach enables the production of customized vaccines within weeks. Despite the optimism, experts warn that developing safe and effective cancer vaccines still requires years of testing, and there are challenges related to public confidence and continuous funding.
Notice: This Is an AI-Generated Summary
Comments (0)